Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + SOF/RBV in HCV GT3 Cirrhosis
NCT02304159Phase 4Completed
- Start
- Jan 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daclatasvir in hepatitis C virus infection. Started Jan 2015; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02304159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304159.